dr. koprivnikar discusses flt3 inhibitors in hematologic malignancies
Published 6 years ago • 220 plays • Length 1:44Download video MP4
Download video MP3
Similar videos
-
2:01
leukodepletion filters cells as cell source-megakaryocyte differentiation l protocol preview
-
1:23
the promise of combining venetoclax with gilteritinib for the treatment of flt3-mutated aml
-
0:18
the biggest pigmentation innovation: la roche-posay mela b3 serum
-
6:47
a natural supplement for the skin - polypodium leucotomos
-
1:11
new issue alert: hematology 2019
-
3:39
how liposomal glutathione helps support healthy aging
-
47:39
new generation b-lactam/b-lactamase inhibitors: taniborbactam
-
47:43
understanding immune activation and evasion in the tumor microenvironment: why lymphocyte...
-
1:39
research that sheds light on the mechanism of action of pml in triple negative breast cancer
-
2:38
nivolumab and ipilimumab with tumour-infiltrating lymphocytes to treat triple-negative breast ca...
-
4:35
biallelic bcma loss causes anti-bcma car-t resistance in myeloma
-
0:56
xtrac laser for vitiligo | metropolis dermatology
-
49:38
julian lum - the metabolic microenvironment in tumors and its impact on t cell mediated immunity
-
0:10
complete antibac solutions
-
0:17
leukoplast leukomed sorbact 3pcs 8cm x 10cm 79950 05
-
11:47
use of micro short pulse erbium yag laser for management of vitiligo and leukotrekia
-
1:54
dr. wang discusses treatment options for flt3-mutated aml
-
1:04
flt3 inhibitors – an ideal strategy for treating flt3-mutated aml
-
0:29
embl scientists exploring synthetic antibodies to stop coronavirus
-
6:18
mutations in glialcam can cause the leukodystrophy mlc
-
1:37
progress with monoclonal antibodies in plasma cell neoplasms
-
1:31
liso-cel vs tisa-cel in third-line dlbcl treatment